Randomized Controlled Trial of Home Therapy With Caffeine Citrate in Moderately Preterm Infants With Apnea of Prematurity
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Caffeine (Primary) ; Caffeine (Primary)
- Indications Apnoea
- Focus Therapeutic Use
- Acronyms MoCHA
- 31 Aug 2018 Biomarkers information updated
- 27 Jun 2018 Planned End Date changed from 1 Jun 2022 to 1 Oct 2022.
- 27 Jun 2018 Planned primary completion date changed from 1 Jun 2022 to 1 Oct 2022.